FILE PHOTO: A smartphone with a Neuralink logo displayed is placed on a computer motherboard in this illustration taken on May 15, 2024. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) - Some of the staff at Elon Musk's Neuralink are making preparations to sell the brain implant company's stock in the wake of its valuation jumping following its first human trial, according to people familiar with the matter.
Stock compensation is a big incentive for employees at startups such as Neuralink. The shares they receive are not publicly traded, and employees that want to sell them without the company's blessing have to use complex turnarounds on niche private market exchanges.
